Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir

Remdesivir (RDV) is a direct-acting antiviral agent that is approved in several countries for the treatment of coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2. RDV exhibits broad-spectrum antiviral activity against positive-sense RNA viruses, for example, sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Calvin J., Lee, Hery W., Tchesnokov, Egor P., Perry, Jason K., Feng, Joy Y., Bilello, John P., Porter, Danielle P., Götte, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695323/
https://www.ncbi.nlm.nih.gov/pubmed/34953856
http://dx.doi.org/10.1016/j.jbc.2021.101529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695323/
https://www.ncbi.nlm.nih.gov/pubmed/34953856
http://dx.doi.org/10.1016/j.jbc.2021.101529

Ejemplares similares